Steven Syre November 12, 2013 The article profiles Kevin Tabb, chief executive officer of Beth Israel Deaconess Medical Center and HMS professor of medicine, and what he has accomplished since arriving two years ago. Read full article
Researchers Discover Bias in AI Models That Analyze Pathology Samples December 16, 2025 The team created a new tool that reduces bias and improves cancer diagnosis across populations
New Artificial Intelligence Model Could Speed Rare Disease Diagnosis November 24, 2025 PopEVE can identify genetic variants most likely to cause severe disease, death
Gordon Freeman, Arlene Sharpe Receive Inaugural Gretener-Thürlemann Prize December 4, 2025 $625,000 prize recognizes breakthrough research into cancer immunotherapy
